Cargando…

A pharmacological screen for compounds that rescue the developmental lethality of a Drosophila ATM mutant

Ataxia-telangiectasia (A-T) is a neurodegenerative disease caused by mutation of the A-T mutated (ATM) gene. ATM encodes a protein kinase that is activated by DNA damage and phosphorylates many proteins, including those involved in DNA repair, cell cycle control, and apoptosis. Characteristic biolog...

Descripción completa

Detalles Bibliográficos
Autores principales: Rimkus, Stacey A., Wassarman, David A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5770031/
https://www.ncbi.nlm.nih.gov/pubmed/29338042
http://dx.doi.org/10.1371/journal.pone.0190821
_version_ 1783293009172889600
author Rimkus, Stacey A.
Wassarman, David A.
author_facet Rimkus, Stacey A.
Wassarman, David A.
author_sort Rimkus, Stacey A.
collection PubMed
description Ataxia-telangiectasia (A-T) is a neurodegenerative disease caused by mutation of the A-T mutated (ATM) gene. ATM encodes a protein kinase that is activated by DNA damage and phosphorylates many proteins, including those involved in DNA repair, cell cycle control, and apoptosis. Characteristic biological and molecular functions of ATM observed in mammals are conserved in Drosophila melanogaster. As an example, conditional loss-of-function ATM alleles in flies cause progressive neurodegeneration through activation of the innate immune response. However, unlike in mammals, null alleles of ATM in flies cause lethality during development. With the goals of understanding biological and molecular roles of ATM in a whole animal and identifying candidate therapeutics for A-T, we performed a screen of 2400 compounds, including FDA-approved drugs, natural products, and bioactive compounds, for modifiers of the developmental lethality caused by a temperature-sensitive ATM allele (ATM(8)) that has reduced kinase activity at non-permissive temperatures. Ten compounds reproducibly suppressed the developmental lethality of ATM(8) flies, including Ronnel, which is an organophosphate. Ronnel and other suppressor compounds are known to cause mitochondrial dysfunction or to inhibit the enzyme acetylcholinesterase, which controls the levels of the neurotransmitter acetylcholine, suggesting that detrimental consequences of reduced ATM kinase activity can be rescued by inhibiting the function of mitochondria or increasing acetylcholine levels. We carried out further studies of Ronnel because, unlike the other compounds that suppressed the developmental lethality of homozygous ATM(8) flies, Ronnel was toxic to the development of heterozygous ATM(8) flies. Ronnel did not affect the innate immune response of ATM(8) flies, and it further increased the already high levels of DNA damage in brains of ATM(8) flies, but its effects were not harmful to the lifespan of rescued ATM(8) flies. These results provide new leads for understanding the biological and molecular roles of ATM and for the treatment of A-T.
format Online
Article
Text
id pubmed-5770031
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-57700312018-01-23 A pharmacological screen for compounds that rescue the developmental lethality of a Drosophila ATM mutant Rimkus, Stacey A. Wassarman, David A. PLoS One Research Article Ataxia-telangiectasia (A-T) is a neurodegenerative disease caused by mutation of the A-T mutated (ATM) gene. ATM encodes a protein kinase that is activated by DNA damage and phosphorylates many proteins, including those involved in DNA repair, cell cycle control, and apoptosis. Characteristic biological and molecular functions of ATM observed in mammals are conserved in Drosophila melanogaster. As an example, conditional loss-of-function ATM alleles in flies cause progressive neurodegeneration through activation of the innate immune response. However, unlike in mammals, null alleles of ATM in flies cause lethality during development. With the goals of understanding biological and molecular roles of ATM in a whole animal and identifying candidate therapeutics for A-T, we performed a screen of 2400 compounds, including FDA-approved drugs, natural products, and bioactive compounds, for modifiers of the developmental lethality caused by a temperature-sensitive ATM allele (ATM(8)) that has reduced kinase activity at non-permissive temperatures. Ten compounds reproducibly suppressed the developmental lethality of ATM(8) flies, including Ronnel, which is an organophosphate. Ronnel and other suppressor compounds are known to cause mitochondrial dysfunction or to inhibit the enzyme acetylcholinesterase, which controls the levels of the neurotransmitter acetylcholine, suggesting that detrimental consequences of reduced ATM kinase activity can be rescued by inhibiting the function of mitochondria or increasing acetylcholine levels. We carried out further studies of Ronnel because, unlike the other compounds that suppressed the developmental lethality of homozygous ATM(8) flies, Ronnel was toxic to the development of heterozygous ATM(8) flies. Ronnel did not affect the innate immune response of ATM(8) flies, and it further increased the already high levels of DNA damage in brains of ATM(8) flies, but its effects were not harmful to the lifespan of rescued ATM(8) flies. These results provide new leads for understanding the biological and molecular roles of ATM and for the treatment of A-T. Public Library of Science 2018-01-16 /pmc/articles/PMC5770031/ /pubmed/29338042 http://dx.doi.org/10.1371/journal.pone.0190821 Text en © 2018 Rimkus, Wassarman http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Rimkus, Stacey A.
Wassarman, David A.
A pharmacological screen for compounds that rescue the developmental lethality of a Drosophila ATM mutant
title A pharmacological screen for compounds that rescue the developmental lethality of a Drosophila ATM mutant
title_full A pharmacological screen for compounds that rescue the developmental lethality of a Drosophila ATM mutant
title_fullStr A pharmacological screen for compounds that rescue the developmental lethality of a Drosophila ATM mutant
title_full_unstemmed A pharmacological screen for compounds that rescue the developmental lethality of a Drosophila ATM mutant
title_short A pharmacological screen for compounds that rescue the developmental lethality of a Drosophila ATM mutant
title_sort pharmacological screen for compounds that rescue the developmental lethality of a drosophila atm mutant
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5770031/
https://www.ncbi.nlm.nih.gov/pubmed/29338042
http://dx.doi.org/10.1371/journal.pone.0190821
work_keys_str_mv AT rimkusstaceya apharmacologicalscreenforcompoundsthatrescuethedevelopmentallethalityofadrosophilaatmmutant
AT wassarmandavida apharmacologicalscreenforcompoundsthatrescuethedevelopmentallethalityofadrosophilaatmmutant
AT rimkusstaceya pharmacologicalscreenforcompoundsthatrescuethedevelopmentallethalityofadrosophilaatmmutant
AT wassarmandavida pharmacologicalscreenforcompoundsthatrescuethedevelopmentallethalityofadrosophilaatmmutant